Evaluation of the effect of oral selenium administration on tremor reduction of Parkinsonians
Phase 2
- Conditions
- Tremor.Parkinson disease
- Registration Number
- IRCT201101155612N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
Inclusions: Idiopathic Parkinson disease; Age between 40 and 60 years; 6 months after diagnosis the disease; stage 2.5 or less based on MODIFIED HOEHN AND YAHR STAGING 5 ; Apparent or troublesome tremor
Exclusions:Other disease induses tremor; out of age range between 40 to 60 years
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tremor rate. Timepoint: At beginning, End of 2 months. Method of measurement: Based on exam,Observation and Physical exam, indices (0-16) will be measured every 2 months (before and after treatment).
- Secondary Outcome Measures
Name Time Method